The engineering of new protein sequences to achieve desired structures and functions.Protein design is the engineering of new protein sequences that fold into specific, predetermined three-dimensional structures and perform desired functions. Unlike natural proteins, which evolved over billions of years, designed proteins are created from scratch using computational methods. This field aims to create novel tools for medicine, industry, and basic research, such as new enzymes, biosensors, and therapeutic agents.
The field was pioneered by David Baker and colleagues at the University of Washington, who developed the Rosetta software in the late 1990s. A major milestone was the 2003 computational design of a novel protein fold, Top7, which had no natural counterpart.
The process typically involves computational algorithms that search the vast space of possible amino acid sequences for those that are likely to fold into a target structure. These algorithms use physical models of atomic interactions and statistical knowledge from known protein structures. The best candidates are then synthesized in the lab and tested experimentally, with iterative refinement to improve stability and function.
Designed proteins are used to create new vaccines, such as the RSV vaccine, and are being developed for targeted drug delivery, biosensors, and industrial enzymes that can break down plastics or other pollutants.
In 2020, a team used protein design to create a novel protein that could bind the spike protein of SARS-CoV-2, potentially blocking the virus from entering cells.




















